At Sunovion, patients are at the center of everything we do
We are creating innovative psychiatric, neurological and respiratory therapies that help transform people's lives, while at the same time we are playing an increasingly active role in the future of global health.
APTIOM is a once-daily prescription medicine that has been approved by the FDA to treat partial-onset seizures in patients 4 years of age and older.
Sunovion Pharmaceuticals video
Copyright © 2021 Maine Neurological Society - All Rights Reserved.